Last week, Adaptive customers at the NCI, along with a collaborator at the University of Maryland School of Medicine published results from a study in which they used the immunoSEQ assay to the importance of the expression of ATM (which … Continue reading
This week, an international team consisting of Adaptive collaborators from Bar Ilan University, the University of Pennsylvania and Rinat-Pfizer published results from a study in which they used the immunoSEQ assay to study DH gene reading frame usage in the … Continue reading
Last week, the Cancer Immunotherapy Consortium (CIC) held its annual meeting in Washington, DC, entitled “Entering the Era of Combination Therapies: Practical Implementation.” The meeting was focused on the complexity of developing combination cancer immunotherapies in light of the … Continue reading
Adaptive Biotechnologies will be giving an Exhibitor Workshop entitled “High-Throughput Sequencing of T cell and B cell Receptors Using immunoSEQ” at the annual American Association of Immunologists (AAI) meeting on Saturday May 4th at 2:00pm in Honolulu, Hawaii. Come learn … Continue reading
A 9 year old from Redmond, OR with acute lymphoblastic leukemia is in remission after receiving an experimental modified T cell treatment, according to a post on her father’s Facebook page. Similar to the results previously published by Stephan Grupp … Continue reading
In the cancer field we have been at ‘war’ for more than 40 years – ever since the signing of the National Cancer Act in 1971 by President Richard Nixon. Yesterday the NY Times published a great article titled ‘Cancer … Continue reading
Q: You mentioned working with many different sample types, can you share you experience and requirements for some limiting sample types such as CSF or Synovial fluid? (Sample Preparations) A: We’ve sequenced T and B cells from a wide variety … Continue reading
One of the recurrent questions that we field is whether our assay is limited to genomic DNA (gDNA), or can also be applied to cDNA. The answer is a little bit complicated, so please bear with me. First, to be … Continue reading
This week, the Supreme Court is hearing oral arguments in a case, Association for Molecular Pathology v. Myriad Genetics, that will determine the legal validity of patents on genetic testing for BRCA-1 and BRCA-2. Genotype at these two loci is … Continue reading
At the recent annual meeting of the American Association of Cancer Research (AACR) much attention was paid to new immunotherapeutic approaches to cancer based on harnessing a patient’s immune response to recognize and eliminate malignant cells. The immune system is … Continue reading
